CAT and neoplasm: The over-expression of folate (FA) receptor on tumor cells including breast, lungs, kidneys, ovaries, colon, brain, etc. has also been exploited for delivery of FA-modified oxygen-based NCs to tumors, such as FA-modified CAT-based liposomes for breast tumor hypoxia alleviation (Shi et al., 2020).